Advantage Alpha Capital Partners LP Has $5.39 Million Position in Clarivate Plc (NYSE:CLVT)

Advantage Alpha Capital Partners LP cut its holdings in shares of Clarivate Plc (NYSE:CLVT) by 30.1% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 759,171 shares of the company’s stock after selling 326,993 shares during the quarter. Clarivate comprises about 1.2% of Advantage Alpha Capital Partners LP’s holdings, making the stock its 29th largest position. Advantage Alpha Capital Partners LP’s holdings in Clarivate were worth $5,390,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in CLVT. Sei Investments Co. lifted its holdings in shares of Clarivate by 391.8% during the first quarter. Sei Investments Co. now owns 72,571 shares of the company’s stock worth $539,000 after purchasing an additional 57,815 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in Clarivate by 5.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 247,446 shares of the company’s stock worth $1,839,000 after buying an additional 13,103 shares during the period. SkyView Investment Advisors LLC increased its stake in shares of Clarivate by 3.8% in the first quarter. SkyView Investment Advisors LLC now owns 131,864 shares of the company’s stock valued at $980,000 after buying an additional 4,789 shares during the period. Boston Partners increased its stake in shares of Clarivate by 76.3% in the first quarter. Boston Partners now owns 557,496 shares of the company’s stock valued at $4,140,000 after buying an additional 241,292 shares during the period. Finally, Transcend Capital Advisors LLC bought a new position in shares of Clarivate during the second quarter worth about $86,000. 85.72% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

CLVT has been the subject of a number of recent analyst reports. Barclays decreased their target price on shares of Clarivate from $5.00 to $4.00 and set an “underweight” rating for the company in a research report on Thursday, November 7th. William Blair cut shares of Clarivate from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada dropped their target price on shares of Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a report on Thursday, November 7th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $7.25.

Clarivate Stock Performance

Shares of CLVT stock opened at $5.74 on Tuesday. The firm has a 50 day moving average of $6.17 and a 200-day moving average of $6.11. The company has a market cap of $4.08 billion, a price-to-earnings ratio of -2.88 and a beta of 1.18. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.84. Clarivate Plc has a 52 week low of $4.25 and a 52 week high of $9.60.

Clarivate (NYSE:CLVT) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.19 EPS for the quarter, hitting analysts’ consensus estimates of $0.19. Clarivate had a negative net margin of 50.00% and a positive return on equity of 9.69%. The business had revenue of $622.20 million during the quarter, compared to analysts’ expectations of $640.81 million. During the same period last year, the company posted $0.18 earnings per share. The business’s quarterly revenue was down 3.9% on a year-over-year basis. On average, equities analysts forecast that Clarivate Plc will post 0.63 earnings per share for the current year.

Insider Activity at Clarivate

In related news, Director Saurabh Saha sold 17,646 shares of Clarivate stock in a transaction on Friday, August 30th. The shares were sold at an average price of $6.75, for a total value of $119,110.50. Following the completion of the sale, the director now owns 23,741 shares of the company’s stock, valued at approximately $160,251.75. This trade represents a 42.64 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Bar Veinstein sold 60,000 shares of the company’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $7.00, for a total transaction of $420,000.00. Following the transaction, the insider now owns 916,583 shares in the company, valued at approximately $6,416,081. The trade was a 6.14 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 197,646 shares of company stock valued at $1,379,111 in the last three months. Corporate insiders own 23.14% of the company’s stock.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.